Annual report pursuant to Section 13 and 15(d)

Income Taxes - Components of deferred Tax Assets and Deferred Tax Liabilities (Detail)

v3.21.2
Income Taxes - Components of deferred Tax Assets and Deferred Tax Liabilities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2021
Jun. 30, 2020
Deferred tax assets:    
Non-capital losses carried forward $ 20,148 $ 11,871
Stock-based compensation 155  
Capital losses carried forward 18 18
Financing costs 326 221
Scientific research and development 761 604
Scientific research and development – Investment Tax Credits (“ITC”) 665 534
Deferred tax assets 22,073 13,248
Deferred tax liabilities:    
Scientific research and development – ITC (110) (88)
Gross future tax assets 21,963 13,160
Valuation allowance (21,963) (13,160)
Net future tax assets